Carfilzomib significantly improves the progression-free survival of high-risk patients in multiple myeloma.
暂无分享，去创建一个
Michael L. Wang | M. Dimopoulos | A. Palumbo | R. Fonseca | A. Jakubowiak | D. Siegel | R. Hájek | A. Oriol | P. Moreau | H. Avet-Loiseau | A. Stewart | V. Kukreti | G. Mihaylov | T. Masszi | L. Rosiñol | M. Mateos | W. Bensinger | D. Ben‐Yehuda | I. Špička | J. Minařík | R. Niesvizky | V. Maisnar | V. Goranova-Marinova | M. Obreja | D. Ben-yehuda | A. Stewart